Cell extracts, in addition to living cells, have 17 amino acids, five B vitamins, folic acid, calcium, iron, heparin, coenzymeQ10, cytochrome C and mesoglycan. In a clinical study, the use of cell therapy in patients affected by chronic atherosclerotic arteriopathies showed a significant increase in femoral venous blood flow and an anticoagulant activity. Folic acid is reported to reduce the oxidation of cholesterol. Coenzyme Q10 assists the heart muscle in energy production. Cytochrome C helps all cells in the body convert oxygen and nutrients to energy.

Dr. G. Laurora and researchers from the Cardiovascular Institute conducted double-blind trials on patients with early stages of arteriosclerosis (clogged arteries). Half of the patients received cell therapy, and half took a placebo. A small section of one artery was scanned with high-resolution ultrasound before and after treatment. At the end of 18 months, the occlusion of the arteries of the patients taking the placebo had increased seven times more than those taking cell therapy. Several clinical trials have shown that cell therapy also deters blood clots and reduces the risk of strokes, even for people who have severely clogged arteries. Dr. F. Vecchio found that patients given cell therapy for only 15 days experienced a 20% drop in "bad" cholesterol and 44% increase in "good" cholesterol.

Dr. Massimo Fedrico guided a double-blind clinical trial of 134 people undergoing chemotherapy. Half of the patients were given cell therapy, and they lived 49% longer than those taking a placebo.

The result of the clinical revitalization study done by Rietschel in 1957 is very interesting. A revitalization effect in 98.5% of the 378 treated cases has been noted. The average duration of the effect lasted between 6 to 12 months, in some even more than 2 years.

Dr. W. Boecker directed a double-blind clinical trial on 146 patients with cirrhosis of the liver. Half were given a placebo, and half took a life cell extract. Sixty-seven percent of those taking the live cell extract had significant improvement in liver function.

In another double-blind study of 600 patients suffering from hepatitis, Dr. Kiyoshi Fujisawa at the Jikei University School of Medicine in Tokyo, showed that, in only 12 weeks, 35% of the patients taking a live cell extract showed substantial improvement.

The Nobel Prize in Medicine and Physiology was awarded to Dr.’s Peter Medawar and Macfarlane Burnett in 1960, for their work in transplantation immunity. They showed that lyophilized tissue will not provoke an immune reaction. They also showed that fetal cells are less antigenic than any other types of cells.

Dr. Alec Fiocchi led a double-blind clinical trial on patients with chronic respiratory infections. Half of the patients were given cell therapy, and the other half received placebos. In only three months, those taking the cell therapy had 30% fewer infections than the placebo group.

Dr. V. Cangemi followed 25 patients on cell therapy after cancer surgery and found that none of them got infections. Tests showed that their immune systems were substantially bolstered by the cell therapy compared to controls.